Financials
- Market Capitalization 233.81 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3487 | ACIU AC Immune SA - Common Stock | 2.45 USD | 0.00% | -3.54% | +6.06% | +15.02% | 249.27 M USD | ||
| 3518 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.59 USD | +1.41% | -6.51% | 0.00% | -54.67% | 239.21 M USD | ||
| 3530 | AGEN Agenus Inc. - Common Stock | 5.62 USD | -8.17% | +62.43% | +67.26% | -18.08% | 234.03 M USD | ||
| 3533 | IVVD Invivyd, Inc. - Common Stock | 0.79 USD | 0.00% | -15.96% | -2.47% | +9.72% | 232.74 M USD |
Frequently asked questions about Protara Therapeutics, Inc. - Common Stock
What is the Protara Therapeutics, Inc. - Common Stock stock price today?
The current price of Protara Therapeutics, Inc. - Common Stock (TARA) is 4.16. Over the past 24 hours, the stock has changed by -0.48%. Follow the TARA chart for real-time price dynamics.
What is the stock ticker of Protara Therapeutics, Inc. - Common Stock?
Protara Therapeutics, Inc. - Common Stock trades under the ticker TARA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Protara Therapeutics, Inc. - Common Stock stock going up?
TARA has changed by -3.48% over the last week, +5.58% over the last month, and +30.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Protara Therapeutics, Inc. - Common Stock net income for the last quarter?
Protara Therapeutics, Inc. - Common Stock reported net income of -17.78 M for the last quarter. The previous quarter showed -17.31 M, which means net income changed by -2.74%.
How many employees does Protara Therapeutics, Inc. - Common Stock have?
As of the latest available data, Protara Therapeutics, Inc. - Common Stock has 51 employees. Workforce size can provide additional context about the company's scale and operations.
What is Protara Therapeutics, Inc. - Common Stock EBITDA?
Protara Therapeutics, Inc. - Common Stock EBITDA is -19.53 M, and its EBITDA margin is -244.14 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Protara Therapeutics, Inc. - Common Stock stock?
You can buy Protara Therapeutics, Inc. - Common Stock (TARA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Protara Therapeutics, Inc. - Common Stock stock?
Investing in Protara Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TARA chart and related analysis on metatrader.com as part of your research.